Abstract:Background Blood leukocyte counts are important biomarkers for the onset of systemic lupus erythematosus (SLE)[1-3]. However, the causal relationship is unclear. Objectives We implement a two-sample Mendelian Randomization (MR) analysis to investigate the potential association. Methods The summary statistics of blood leukocyte counts were available from public databases (n=172435)[4]. The SNPs related to SLE risk were extracted from a large SLE GWAS with 5201 cases and 9066 controls of European ancestry[5]. All genetic variants significantly associated with blood leukocyte counts (p<5×10-8) were used as instrumental variables (IVs). Then, the linkage disequilibrium (LD) was excluded (distance threshold = 10,000 kb, r2 = 0.001). In this study, the inverse variance weighted (IVW) method, the MR-Egger method, and the weighted median (WM) were used to estimate the causal effect of the blood leukocyte counts and SLE. In addition, Cochran’s Q test, MR pleiotropy residual sum and outlier (MR-PRESSO), and leave-one-out analysis were implemented as sensitivity tests. Results We selected 119 independent SNPs as IVs in the MR analysis of total WBC. Higher blood leukocyte counts were associated with a lower risk of SLE (OR:0.629, 95% CI: 0.436-0.907, P: 0.013) by IVW method (Figure 1). However, the results of Cochrane Q statistics showed heterogeneity (p<0.05). Therefore, we used the random-effects model[6]. Conclusion Our study predicted genetically that individuals with lower blood leukocyte counts face a higher risk of SLE, which was consistent with the previous observational studies. References [1]Messner, R.P., F.D. Lindström, and R.C. Williams, Jr., Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus. J Clin Invest, 1973. 52(12): p. 3046-56. [2]Nakano, M., et al., Increased Proportion of CD226(+) B Cells Is Associated With the Disease Activity and Prognosis of Systemic Lupus Erythematosus. Front Immunol, 2021. 12: p. 713225. [3]Martínez-Baños, D., et al., Moderate and severe neutropenia in patients with systemic lupus erythematosus. Rheumatology (Oxford), 2006. 45(8): p. 994-8. [4]Astle, W.J., et al., The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease. Cell, 2016. 167(5): p. 1415-1429.e19. [5]Bentham, J., et al., Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat Genet, 2015. 47(12): p. 1457-1464. [6]DerSimonian, R. and N. Laird, Meta-analysis in clinical trials. Control Clin Trials, 1986. 7(3): p. 177-88. Acknowledgements: NIL. Disclosure of Interests None Declared.

Single-cell expression quantitative trait loci (eQTL) analysis of SLE-risk loci in lupus patient monocytes

Novel Long Non-coding RNA Expression Profile of Peripheral Blood Mononuclear Cells Reveals Potential Biomarkers and Regulatory Mechanisms in Systemic Lupus Erythematosus

Deciphering cell-specific genetic insights: Unraveling the immunogenetic landscape of systemic lupus erythematosus

Single-cell gene expression patterns in lupus monocytes independently indicate disease activity, interferon and therapy

Single-cell RNA-seq reveals cell type–specific molecular and genetic associations to lupus

Genome-Wide Identification of Cell Type-Specific Susceptibility Genes for SLE Through the Analysis of RNA Modification-Associated SNPs

Peripheral mononuclear cells and systemic lupus erythematosus association: Integrated study of single-cell sequencing and mendelian randomization analysis

-eQTL mapping prioritises as a negative regulator of interferon response at a lupus risk locus

modulates lupus risk via negative regulation of interferon response

Mapping systemic lupus erythematosus heterogeneity at the single-cell level

Biological Insights into Systemic Lupus Erythematosus Through an Immune Cell-Specific Transcriptome-Wide Association Study

The Chromatin Accessibility Landscape of Peripheral Blood Mononuclear Cells in Patients with Systemic Lupus Erythematosus at Single-Cell Resolution.

Several Critical Cell Types, Tissues, and Pathways Are Implicated in Genome-Wide Association Studies for Systemic Lupus Erythematosus

High-throughput identification of functional regulatory SNPs in systemic lupus erythematosus

3 Confirmation of 5 novel susceptibility loci for systemic lupus erythematosus (sle) and integrated network analysis of 82 sle susceptibility loci

Investigation of C1-complex Regions Reveals New C1Q Variants Associated with Protection from Systemic Lupus Erythematosus, and Affect Its Transcript Abundance

Global discovery of lupus genetic risk variant allelic enhancer activity

Trans-ancestral Studies Fine Map the SLE-susceptibility Locus TNFSF4.

Confirmation of Five Novel Susceptibility Loci for Systemic Lupus Erythematosus (SLE) and Integrated Network Analysis of 82 SLE Susceptibility Loci

Analysis of Trans-Ancestral SLE Risk Loci Identifies Unique Biologic Networks and Drug Targets in African and European Ancestries

AB0145 GENETIC EVIDENCE REVEALS A CAUSAL ROLE OF BLOOD LEUKOCYTE COUNTS IN SYSTEMIC LUPUS ERYTHEMATOSUS